CHOICE: Carotid Stenting For High Surgical-Risk Patients

CompletedOBSERVATIONAL
Enrollment

18,855

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Carotid Artery Disease
Interventions
DEVICE

RX ACCULINK , RX ACCUNET , XACT , EMBOSHIELD and EMBOSHIELD Nav6

Provide an ongoing post-market surveillance mechanism for documentation of clinical outcomes and for possible extension of the Centers for Medicare and Medicaid Services (CMS) coverage to a broader group of patients.

Trial Locations (1)

95054

Abbott Vascular, Santa Clara

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY